Synergistic antiosteoporotic effect of Lepidium Sativum and alendronate in glucocorticoid-induced osteoporosis in wistar rats
Authors:
- Mf ElshalMf Elshal
- AL AlmalkiAAAL Almalki
- Hk HusseinHHHk Hussein
- Ja KhanJKJa Khan
- 14 August 2013
- journal article
- research article
- Published by African Journals Online (AJOL) in African Journal of Traditional, Complementary and Alternative Medicines
- Vol. 10 (5) , 267-273-273
Abstract
Alendronate belongs to a class of drugs called bisphosphonates. Bisphosphonates (BP) therapy is a vital option to reduce the risk of bone fracture in people who suffer from osteoporosis. Yet, bisphosphonate have displayed several side effects. Lepidium sativum (LS) seeds have been used in traditional folk medicine to heal fractured bones. However, there is a dearth of information on the impact of LS on bone metabolism especially in cases of glucocorticoids induced osteoporosis. Therefore, the aim of the study was to compare the biochemical bone markers and histological responses of LS alone (6 g of LS seeds in diet daily, n=8), ALD (alendronate, 70 mg/kg s.c.; n=8) alone, or LS and ALD combined in a rat model of glucocorticoid-induced osteoporosis (GIO) by injecting rats with methylprednisolone 3.5 mg/kg per day for 4 weeks. Serum calcium (Ca), albumin, phosphorus (P), bone-specific alkaline phosphatase (b-ALP), and tartrate-resistant acid phosphatase (TRAP) were measured 4 weeks after induction of GIO. GIO-group showed significantly increased serum TRAP and decreased b-ALP. GIO-group also showed significantly decreased serum P and unaltered Ca concentrations. Histological examination of GIO-group tibia bones indicated an osteoporotic change and a concomitant decrease in percentage of trabecular area or bone marrow area (PTB) in the proximal femoral epiphysis. Treatment with either LS and/or ALD ameliorated the above mentioned changes with variable degrees, with a net results of enhanced serum calcium, bone architecture, PTB, b-ALP and decreased TRAP in LS and LS+ALD groups compared to that of animals treated with alendronate alone. In conclusion, our findings present evidence supporting the potential benefits of LS in reducing the burden of GCs on bone health. Keywords: Osteoporosis, Bisphosphonates, Lepidium sativum, bone turnover markersKeywords
This publication has 39 references indexed in Scilit:
- Ethnobiology and Ethnopharmacology ofLepidium meyenii(Maca), a Plant from the Peruvian HighlandsEvidence-Based Complementary and Alternative Medicine, 2012
- Diet Calcium Level but Not Calcium Supplement Particle Size Affects Bone Density and Mechanical Properties in Ovariectomized Rats ,The Journal of Nutrition, 2009
- Screening and Treatment of Glucocorticoid-Induced Osteoporosis in Rheumatoid Arthritis Patients in an Urban Multispecialty PracticeJCR: Journal of Clinical Rheumatology, 2009
- Osteoporosis risk perceptions among patients who have sustained a fragility fracturePatient Education and Counseling, 2009
- Alendronate or Alfacalcidol in Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 2006
- The molecular complexity of glucocorticoid actions in inflammation — a four-ring circusCurrent Opinion in Pharmacology, 2004
- Trabecular Bone Microarchitecture, Bone Mineral Density, and Vertebral Fractures in Male OsteoporosisJournal of Bone and Mineral Research, 2000
- The effects of androgens on the mechanical properties of primate boneBone, 1995
- Calcium and vitamin D enriched diets increase and preserve vertebral mineral content in aging laboratory ratsBone, 1995
- Tartrate-resistant acid phosphatase in mononuclear and multinuclear cells during the bone resorption of tooth eruption.Journal of Histochemistry & Cytochemistry, 1987